PATENT CLAIM ANALYSIS

Application Number: 15743546
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["546", "153000"]

Abstract:
Compounds that inhibit Myeloid Cell Leukemia-1 (Mcl-1) oncoprotein, and methods of using the same, are provided for treating disease.

Claim (Index 6):
The compound of  claim 4 , wherein R 23  and R 24  each independently represent a substituent selected from the group consisting of optionally substituted alkyl and aryl; and R 23  and R 24  can, taken together, comprise an optionally substituted cycloalkyl or heterocycloalkyl ring.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 86.0
- Lexical Diversity: 1.04348
- Patent Class: 546.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12104294', '12096393', '14763468', '13823810', '13526337']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7883576673211115
- 35 USC 102 Novelty (BERT): 0.5087590704152616
- Combined Prediction Score: 0.7603978076305264
- Mean Citation Score: 268.77087199999994
- Max Citation Score: 276.15472
- Similarity Product: 203.23744693653103

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test